Literature DB >> 2281232

Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk.

C P Farrington1, G Manning.   

Abstract

When it is required to establish a materially significant difference between two treatments, or, alternatively, to show that two treatments are equivalent, standard test statistics and sample size formulae based on a null hypothesis of no difference no longer apply. This paper reviews some of the test statistics and sample size formulae proposed for comparative binomial trials when the null hypothesis is of a specified non-zero difference or non-unity relative risk. Methods based on restricted maximum likelihood estimation are recommended and applied to studies of pertussis vaccine.

Mesh:

Year:  1990        PMID: 2281232     DOI: 10.1002/sim.4780091208

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  105 in total

Review 1.  Vaccine trials.

Authors:  C P Farrington; E Miller
Journal:  Mol Biotechnol       Date:  2001-01       Impact factor: 2.695

2.  Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

Authors:  Laura Mauri; Dean J Kereiakes; Robert W Yeh; Priscilla Driscoll-Shempp; Donald E Cutlip; P Gabriel Steg; Sharon-Lise T Normand; Eugene Braunwald; Stephen D Wiviott; David J Cohen; David R Holmes; Mitchell W Krucoff; James Hermiller; Harold L Dauerman; Daniel I Simon; David E Kandzari; Kirk N Garratt; David P Lee; Thomas K Pow; Peter Ver Lee; Michael J Rinaldi; Joseph M Massaro
Journal:  N Engl J Med       Date:  2014-11-16       Impact factor: 91.245

3.  Profile Likelihood and Incomplete Data.

Authors:  Zhiwei Zhang
Journal:  Int Stat Rev       Date:  2010-04-01       Impact factor: 2.217

4.  Phase III trial comparing UFT + PSK to UFT + LV in stage IIB, III colorectal cancer (MCSGO-CCTG).

Authors:  Yasuhiro Miyake; Junichi Nishimura; Takeshi Kato; Masataka Ikeda; Masaki Tsujie; Taishi Hata; Ichiro Takemasa; Tsunekazu Mizushima; Hirofumi Yamamoto; Mitsugu Sekimoto; Riichiro Nezu; Yuichiro Doki; Masaki Mori
Journal:  Surg Today       Date:  2017-06-20       Impact factor: 2.549

5.  Methods for equivalence and noninferiority testing.

Authors:  Gisela Tunes da Silva; Brent R Logan; John P Klein
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742

6.  Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.

Authors:  John B Holcomb; Barbara C Tilley; Sarah Baraniuk; Erin E Fox; Charles E Wade; Jeanette M Podbielski; Deborah J del Junco; Karen J Brasel; Eileen M Bulger; Rachael A Callcut; Mitchell Jay Cohen; Bryan A Cotton; Timothy C Fabian; Kenji Inaba; Jeffrey D Kerby; Peter Muskat; Terence O'Keeffe; Sandro Rizoli; Bryce R H Robinson; Thomas M Scalea; Martin A Schreiber; Deborah M Stein; Jordan A Weinberg; Jeannie L Callum; John R Hess; Nena Matijevic; Christopher N Miller; Jean-Francois Pittet; David B Hoyt; Gail D Pearson; Brian Leroux; Gerald van Belle
Journal:  JAMA       Date:  2015-02-03       Impact factor: 56.272

7.  Results from a randomized clinical trial of coadministration of RotaTeq, a pentavalent rotavirus vaccine, and NeisVac-C, a meningococcal serogroup C conjugate vaccine.

Authors:  Timo Vesikari; Aino Karvonen; Ray Borrow; Nick Kitchin; Martine Baudin; Stéphane Thomas; Anne Fiquet
Journal:  Clin Vaccine Immunol       Date:  2011-03-09

8.  Randomised double-blind comparison of oral gatifloxacin and co-amoxiclav for acute exacerbation of chronic Bronchitis.

Authors:  M Solèr; H Lode; R Baldwin; J H A Levine; A J M Schreurs; J A van Noord; F P V Maesen; M Zehrer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-05       Impact factor: 3.267

9.  A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda.

Authors:  Steven J Reynolds; Cissy Kityo; Claire W Hallahan; Geoffrey Kabuye; Diana Atwiine; Frank Mbamanya; Francis Ssali; Robin Dewar; Marybeth Daucher; Richard T Davey; Peter Mugyenyi; Anthony S Fauci; Thomas C Quinn; Mark R Dybul
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

10.  Rationale and design: telepsychology service delivery for depressed elderly veterans.

Authors:  Leonard E Egede; Christopher B Frueh; Lisa K Richardson; Ronald Acierno; Patrick D Mauldin; Rebecca G Knapp; Carl Lejuez
Journal:  Trials       Date:  2009-04-20       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.